A prospective, iterative, adaptive trial of carfilzomib‐based desensitization - Tremblay - 2020 - American Journal of Transplantation - Wiley Online Library
Carfilzomib - Wikipedia
Proteasome inhibitors - ScienceDirect
H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth | Scientific Reports
Late Breaking Abstract – ASH 2019: DARZALEX®, KYPROLIS® and Dexamethasone Combination Improves PFS in Relapsed or Refractory Multiple Myeloma – OncoPrescribe
Carfilzomib: Proteasome Inhibitors for Treatment of Multiple Myeloma Patients | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives
Carfilzomib: Structure and biochemical features. | Download Scientific Diagram
Frontiers | Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma | Oncology
Comparison of the inhibitor type, mechanisms, and adverse side effects... | Download Scientific Diagram
Proteasome Inhibitors as Sensitizing Agents for Cancer Chemotherapy - ScienceDirect
The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia | Oncology - Frontiers
Novel Targeted Agents in the Treatment of Multiple Myeloma - Hematology/Oncology Clinics
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling
Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma | Leukemia
Bortezomib-Resistant Mutant Proteasomes: Structural and Biochemical Evaluation with Carfilzomib and ONX 0914 - ScienceDirect
Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin - ScienceDirect
IJMS | Free Full-Text | Cellular Responses to Proteasome Inhibition: Molecular Mechanisms and Beyond | HTML
Resistance Mechanisms to Novel Therapies in Myeloma | IntechOpen
Carfilzomib May Offer Advantages in Patients with Relapsed/Refractory Multiple Myeloma - The ASCO Post
Cardiac Considerations for Modern Multiple Myeloma Therapies - American College of Cardiology
Carfilzomib: new drug for multiple myeloma - info-farmacia
Carfilzomib Mechanism of Action | KYPROLIS&® (carfilzomib)
